Evidence map›Paper›PMID 37630743›Full record

ArticleNutrients2023

Diosgenin Targets CaMKK2 to Alleviate Type II Diabetic Nephropathy through Improving Autophagy, Mitophagy and Mitochondrial Dynamics.

Yujie Zhong, Ruyi Jin, Ruilin Luo, Jiayu Liu, Luting Ren, Yinghan Zhang, Zhongguo Shan, Xiaoli Peng

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Yujie ZhongCollege of Food Science and Engineering, Northwest A&F University, Yangling 712100, China.
Ruyi JinCollege of Food Science and Engineering, Northwest A&F University, Yangling 712100, China.
Ruilin LuoCollege of Food Science and Engineering, Northwest A&F University, Yangling 712100, China.
Jiayu LiuCollege of Food Science and Engineering, Northwest A&F University, Yangling 712100, China.
Luting RenCollege of Food Science and Engineering, Northwest A&F University, Yangling 712100, China.
Yinghan ZhangCollege of Food Science and Engineering, Northwest A&F University, Yangling 712100, China.
Zhongguo ShanCollege of Food Science and Engineering, Northwest A&F University, Yangling 712100, China.
Xiaoli PengCollege of Food Science and Engineering, Northwest A&F University, Yangling 712100, China.
Northwest A&F University · CNKunming University of Science and Technology · CN

Funding

Student's Platform for Innovation and Entrepreneurship Training Program X202110712054, S202110712619the Science and Technology Plan Project of Shaanxi Province 2020NY-106
6 · The paper itself

Abstract

Diabetic nephropathy (DN) is a worldwide health problem with increasing incidence. Diosgenin (DIO) is a natural active ingredient extracted from Chinese yams (

Indexed as

Diabetes MellitusDiabetic NephropathiesDiosgeninAMP-Activated Protein KinasesAnimalsAutophagyMitochondrial DynamicsMitophagyRatsAMP-Activated Protein KinasesDiosgeninautophagyCaMKK2diabetic nephropathydiosgeninmitochondrial dynamicsmitophagy

Identifiers

PMID37630743
PMCPMC10459415
OpenAlexW4385760494

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.